InvestorsHub Logo
Followers 9
Posts 238
Boards Moderated 0
Alias Born 07/14/2011

Re: readthechinastudy post# 18984

Wednesday, 07/30/2014 8:28:18 PM

Wednesday, July 30, 2014 8:28:18 PM

Post# of 48316
You totally missed the point of my message....Please read again. My concern is not with IL-12 it's that the company may not be following up with the sites enough to keep the trials moving along. I've spent many years in industry doing just that. I've worked in clinical development for Merck, JNJ and Novartis and know from experience that you have to constantly follow-up with sites to keep things moving.

As you can tell from my posts, I do a lot of DD on companies and their staff. Take a look at the work experience for the Executive Director of Clinical Development -

Executive Director, Clinical Development
OncoSec Medical Inc
April 2013 – Present (1 year 4 months)Greater San Diego Area
OncoSec Medical IncDirector, Clinical Operations
OncoSec Medical Inc
February 2011 – April 2013 (2 years 3 months)
Manager, Business Development and Operations
Protox Therapeutics
January 2007 – March 2011 (4 years 3 months)



This guy came to ONCS in 2011 with no prior clinical development experience! Sorry, you need to know the in and outs of clinical development to run the department. Perhaps his Linkedin profile is misleading, but I've seen several examples of the lack of experience at Oncosec (except for Dr. Pierce). Take a look at my past posts for other examples.

I believe in the science, but I need a little more proof that they can pull this off. Before June I had over 500K shares. I've taken some profits and am still in the green. I'm planning to start buying heavy again as soon as I see a clear path forward.